Exact Mass: 853.2699

Exact Mass Matches: 853.2699

Found 89 metabolites which its exact mass value is equals to given mass value 853.2699, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lacto-n-fucopentaose I

N-[(2S,3R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-4-{[(2R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidate

C32H55NO25 (853.3063)


Lacto-n-fucopentaose I is an oligosaccharide found in human milk and other biofluids. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-n-fucopentaose I and its sulfated and sialylated analogs, SuLNFPI and SLNFPI, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. Burkinabe women show lower concentrations of lacto-n-fucopentaose I while Italian women show a higher concentrations of lacto-n-fucopentaose I. Lacto-n-fucopentaose I inhibits blastocyst attachment to uterine epithelial cells in vitro; component(s) carrying LNF-1 in the secretion might be regulatory molecules helping to secure the proper time for implantation. (PMID: 8639679, 16954962, 1802622, 3927775, 2988366) [HMDB] Lacto-n-fucopentaose I is an oligosaccharide found in human milk and other biofluids. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-n-fucopentaose I and its sulfated and sialylated analogs, SuLNFPI and SLNFPI, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. Burkinabe women show lower concentrations of lacto-n-fucopentaose I while Italian women show a higher concentrations of lacto-n-fucopentaose I. Lacto-n-fucopentaose I inhibits blastocyst attachment to uterine epithelial cells in vitro; component(s) carrying LNF-1 in the secretion might be regulatory molecules helping to secure the proper time for implantation. (PMID: 8639679, 16954962, 1802622, 3927775, 2988366).

   

Lacto-N-fucopentaose-2

N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.3063)


Lacto-N-fucopentaose-2 is an oligosaccharide found in human milk and other biofluids. Lacto-N-fucopentaose-2 is an active pentasaccharide of the blood group Lewisa (Lea). Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-N-fucopentaose-2 and its sulfated and sialylated analogs, SuLNFPII and SLNFPII, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. (PMID: 8639679) [HMDB] Lacto-N-fucopentaose-2 is an oligosaccharide found in human milk and other biofluids. Lacto-N-fucopentaose-2 is an active pentasaccharide of the blood group Lewisa (Lea). Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-N-fucopentaose-2 and its sulfated and sialylated analogs, SuLNFPII and SLNFPII, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. (PMID: 8639679).

   

Lacto-N-fucopentaose III

N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.3063)


Lacto-N-fucopentaose III is an oligosaccharide found in human milk. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. (PMID:17002410) [HMDB] Lacto-N-fucopentaose III is an oligosaccharide found in human milk. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. (PMID:17002410).

   

Lex-lactose

N-[(2S,4R,6R)-2-{[(4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-5-{[(2S,3R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.3063)


Lacto-N-fucopentaose III (LNFPIII) is a polylactosamine sugar, predominant carbohydrate found in S. mansoni egg Ag. Lewis type carbohydrate LNFPIII can function as an adjuvant by their ability to induce a Th2 response (PMID:11418681). LNFPIII/LeX is also expressed by immunosuppressive helminth parasites, by bacteria, and on a number of tumor/cancer cells. According to Atochina et al., LNFPIII-stimulated macrophages secrete prostaglandin E(2), interleukin-10 (IL-10), and tumor necrosis factor alpha (TNF-alpha) but a very low level of IL-12. Interestingly, addition of anti-TNF-alpha, anti-IL-10, or anti-IL-12 monoclonal antibodies did not significantly alter NK cell activity. It shows that soluble mediators are not critical for LNFPIII-stimulated macrophage activation of NK cells and provide further evidence for the importance of cell-cell contact and CD40-CD40L interactions between macrophages and NK cells. (PMID:16148169). Lacto-N-fucopentaose III (LNFPIII) is a polylactosamine sugar, predominant carbohydrate found in S. mansoni egg Ag. Lewis type carbohydrate LNFPIII can function as an adjuvant by their ability to induce a Th2 response (PMID:11418681)

   

Lacto-N-fucopentaose V

N-[(3R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(3R,5R)-1,2,5-trihydroxy-6-oxo-4-{[(2S,3S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}oxan-4-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-{[(3R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.3063)


Lacto-N-fucopentaose V is an oligosaccharide found in human milk and other biofluids. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. (PMID: 17002410, 16954962, 1802622, 3927775, 6638472) [HMDB] Lacto-N-fucopentaose V is an oligosaccharide found in human milk and other biofluids. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. (PMID: 17002410, 16954962, 1802622, 3927775, 6638472).

   

Lewis X antigen

N-(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl)ethanimidate

C32H55NO25 (853.3063)


   

1-Hydroxysulfurmycin B

1-Hydroxysulfurmycin B

C43H51NO17 (853.3157)


   

lacto-n-Fucopentaose III

lacto-n-Fucopentaose III

C32H55NO25 (853.3063)


   
   

cyclo[2-(1-methylcyclopropyl)-D-glycine-(2S,3aR,8aS)-6,7-dichloro-3a-hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylic acid-erythro-3-hydroxy-D-glutamic acid-O-methyl-L-serine-L-piperazic acid-(S)-2-hydroxy-3,3-dimethylbutanoic acid]|kutzneride 3

cyclo[2-(1-methylcyclopropyl)-D-glycine-(2S,3aR,8aS)-6,7-dichloro-3a-hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylic acid-erythro-3-hydroxy-D-glutamic acid-O-methyl-L-serine-L-piperazic acid-(S)-2-hydroxy-3,3-dimethylbutanoic acid]|kutzneride 3

C37H49Cl2N7O12 (853.2816)


   

Acetylglucosamine|beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|beta-D-galactopyranosyl-(1->3)-[(alpha-L-fucopyranosyl)-(1->4)]-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose sodium salt|beta-D-Galp(1->3)-[alpha-L-Fucp(1->4)]-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Gal(beta1-3)[Fuc(alpha1-4)]GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose II (LNF II)|Lewis A pentasaccharide

Acetylglucosamine|beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|beta-D-galactopyranosyl-(1->3)-[(alpha-L-fucopyranosyl)-(1->4)]-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose sodium salt|beta-D-Galp(1->3)-[alpha-L-Fucp(1->4)]-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Gal(beta1-3)[Fuc(alpha1-4)]GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose II (LNF II)|Lewis A pentasaccharide

C32H55NO25 (853.3063)


   

alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|alpha-L-Fuc-(1?2)-beta-D-Gal-(1?3)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc|alpha-L-Fucp(1->2)-beta-D-Galp(1->3)-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Fuc(alpha1-2)Gal(beta1-3)GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose I|lacto-neo-fucopentaose|LNF-I

alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|alpha-L-Fuc-(1?2)-beta-D-Gal-(1?3)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc|alpha-L-Fucp(1->2)-beta-D-Galp(1->3)-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Fuc(alpha1-2)Gal(beta1-3)GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose I|lacto-neo-fucopentaose|LNF-I

C32H55NO25 (853.3063)


   

alpha-L-Fuc-(1?2)-beta-D-Gal-(1?4)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc

alpha-L-Fuc-(1?2)-beta-D-Gal-(1?4)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc

C32H55NO25 (853.3063)


   

LNF III

O-6-Deoxy-alpha-L-galactopyranosyl-(1->3)-O-[beta-delta-galactopyranosyl-(1->4)]-O-2-acetamido-2-deoxy-beta-delta-glucopyranosyl-(1->3)-O-beta-delta-galactopyranosyl-(1->4)- D-glucopyranose

C32H55NO25 (853.3063)


   

LNF II

O-6-Deoxy-alpha-L-galactopyranosyl-(1->4)-O-[beta-delta-galactopyranosyl-(1->3)]-O-2-acetamido-2-deoxy-beta-delta-glucopyranosyl-(1->3)-O-beta-delta-galactopyranosyl-(1->4)-delta-glucopyranose

C32H55NO25 (853.3063)


   

LNFP III

O-6-Deoxy-alpha-delta-galactopyranosyl-(1->3)-O-[beta-delta-galactopyranosyl-(1->4)]-O-2-(acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)-O-beta-delta-galactopyranosyl-(1->4)- D-glucose

C32H55NO25 (853.3063)


   

LNF I

lacto-N-fuco-Pentaose I

C32H55NO25 (853.3063)


   

LNFP V

O-6-Deoxy-alpha-L-galactopyranosyl-(1->3)-O-[O-beta-delta-galactopyranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)-beta-delta-galactopyranosyl-(1->4)]-delta-glucose

C32H55NO25 (853.3063)


   

[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene]-dichloro-(thiophen-2-ylmethylidene)ruthenium,tricyclohexylphosphane

[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene]-dichloro-(thiophen-2-ylmethylidene)ruthenium,tricyclohexylphosphane

C44H62Cl2N2PRuS (853.2792)


   
   

Casein

Casein

C47H48N3NaO7S2 (853.2831)


It is used as a food additive .

   

t-BuBrettPhos Palladacycle Gen. 3

t-BuBrettPhos Palladacycle Gen. 3

C44H62NO5PPdS (853.3121)


   

Lacto-N-neofucopentaose I

Lacto-N-neofucopentaose I

C32H55NO25 (853.3063)


   

Brilliant Blue G

Brilliant blue G-250

C47H48N3NaO7S2 (853.2831)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

Lnf-III

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

C32H55NO25 (853.3063)


   

beta-D-Glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1-->4)-O-[beta-D-galactopyranosyl-(1-->3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-->3)-O-beta-D-galactopyranosyl-(1-->4)-

beta-D-Glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1-->4)-O-[beta-D-galactopyranosyl-(1-->3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-->3)-O-beta-D-galactopyranosyl-(1-->4)-

C32H55NO25 (853.3063)


   
   

Lewis a pentasaccharide

Lewis a pentasaccharide

C32H55NO25 (853.3063)


   

lacto-N-fucopentose II

lacto-N-fucopentose II

C32H55NO25 (853.3063)


   

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose

C32H55NO25 (853.3063)


   

Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)a-Glc

Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)a-Glc

C32H55NO25 (853.3063)


   

N-[(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R,6R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide

N-[(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R,6R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide

C32H55NO25 (853.3063)


   

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

GalNAc(b1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)b-Xyl

GalNAc(b1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)b-Xyl

C31H51NO26 (853.2699)


   

6-deoxy-alpha-L-galactopyranosyl-(1->4)-[alpha-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-alpha-D-glucopyranose

6-deoxy-alpha-L-galactopyranosyl-(1->4)-[alpha-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-alpha-D-glucopyranose

C32H55NO25 (853.3063)


   

GalNAc(b1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)Xyl

GalNAc(b1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)Xyl

C31H51NO26 (853.2699)


   

Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)Glc

Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)Glc

C32H55NO25 (853.3063)


   

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

C32H55NO25 (853.3063)


   

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

C32H55NO25 (853.3063)


   

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

C32H55NO25 (853.3063)


   

WURCS=2.0/5,5,4/[hxFFxh][a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5][a2112h-1a_1-5]/1-2-3-4-5/a6-b1_b4-c1_c2-d1_c3-e1

WURCS=2.0/5,5,4/[hxFFxh][a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5][a2112h-1a_1-5]/1-2-3-4-5/a6-b1_b4-c1_c2-d1_c3-e1

C32H55NO25 (853.3063)


   

2-Aminoethyl hexaarabinofuranoside

2-Aminoethyl hexaarabinofuranoside

C32H55NO25 (853.3063)


   

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

C32H55NO25 (853.3063)


   

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

C32H55NO25 (853.3063)


   

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(b1-3)]Glc

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(b1-3)]Glc

C32H55NO25 (853.3063)


   

D-Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

D-Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

D-Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc

D-Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

D-Fuc(a1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

D-Fuc(a1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

Fuc(a1-2)Gal(b1-3)GalNAc(b1-3)Gal(a1-4)b-Glc

Fuc(a1-2)Gal(b1-3)GalNAc(b1-3)Gal(a1-4)b-Glc

C32H55NO25 (853.3063)


   

Fuc(a1-2)Gal(b1-4)GalNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-4)GalNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

C32H55NO25 (853.3063)


   

N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

C32H55NO25 (853.3063)


   

Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

C32H55NO25 (853.3063)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)Gal(b1-4)Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

D-Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

D-Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(a1-3)]Glc

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(a1-3)]Glc

C32H55NO25 (853.3063)


   

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

C32H55NO25 (853.3063)


   

GalNAc(a1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)b-Xyl

GalNAc(a1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)b-Xyl

C31H51NO26 (853.2699)


   

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

GalNAc(a1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)Xyl

GalNAc(a1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)Xyl

C31H51NO26 (853.2699)


   

N-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5S,6S)-6-[[(2S,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy]-2-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

N-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5S,6S)-6-[[(2S,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy]-2-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C32H55NO25 (853.3063)


   

Gal(b1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)b-Glc

Gal(b1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

Fuc(a1-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

Fuc(a1-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

GalNAc(b1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)a-Xyl

GalNAc(b1-4)GlcA(b1-3)Gal(b1-3)Gal(b1-4)a-Xyl

C31H51NO26 (853.2699)


   

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.3063)


   

Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-2Mana

Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-2Mana

C32H55NO25 (853.3063)


   

Lacto-N-Fucopentaose II

Lacto-N-Fucopentaose II

C32H55NO25 (853.3063)


   

Lacto-N-fucopentaose V

Lacto-N-fucopentaose V

C32H55NO25 (853.3063)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.3063)


   

6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)]-D-glucopyranose

6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)]-D-glucopyranose

C32H55NO25 (853.3063)


An amino pentasaccharide comprising of beta-D-gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-gal-(1->4)-D-glc in which the D-glc residue is substituted by an alpha-L-Fuc group at position 3. It is found in human milk.

   

(3r)-3-[(1s,4r,7s,14s,17s,20r,23s,31r)-7-tert-butyl-26,27-dichloro-2,15,18,31-tetrahydroxy-17-(methoxymethyl)-4-(1-methylcyclopropyl)-5,8,21-trioxo-6-oxa-3,9,10,16,19,22,24-heptaazapentacyclo[20.10.0.0⁹,¹⁴.0²³,³¹.0²⁵,³⁰]dotriaconta-2,15,18,25,27,29-hexaen-20-yl]-3-hydroxypropanoic acid

(3r)-3-[(1s,4r,7s,14s,17s,20r,23s,31r)-7-tert-butyl-26,27-dichloro-2,15,18,31-tetrahydroxy-17-(methoxymethyl)-4-(1-methylcyclopropyl)-5,8,21-trioxo-6-oxa-3,9,10,16,19,22,24-heptaazapentacyclo[20.10.0.0⁹,¹⁴.0²³,³¹.0²⁵,³⁰]dotriaconta-2,15,18,25,27,29-hexaen-20-yl]-3-hydroxypropanoic acid

C37H49Cl2N7O12 (853.2816)


   

methyl 4-{[5-({5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl}oxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7,10-tetrahydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

methyl 4-{[5-({5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl}oxy)-4-(dimethylamino)-6-methyloxan-2-yl]oxy}-2,5,7,10-tetrahydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

C43H51NO17 (853.3157)


   

n-(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid

n-(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid

C32H55NO25 (853.3063)


   

n-{1-[2-(4-{[(7,7-dichloro-1-{2-hydroxy-1-[4-(methoxycarbonyl)-1,3-thiazol-2-yl]-2-methylpropoxy}-2-methyl-1-oxooctan-3-yl)oxy]carbonyl}-1,3-thiazol-2-yl)-2-hydroxyethoxy]-3-hydroxy-6-methyl-1-oxoheptan-4-yl}butanimidic acid

n-{1-[2-(4-{[(7,7-dichloro-1-{2-hydroxy-1-[4-(methoxycarbonyl)-1,3-thiazol-2-yl]-2-methylpropoxy}-2-methyl-1-oxooctan-3-yl)oxy]carbonyl}-1,3-thiazol-2-yl)-2-hydroxyethoxy]-3-hydroxy-6-methyl-1-oxoheptan-4-yl}butanimidic acid

C36H53Cl2N3O12S2 (853.2448)


   

n-[(3r,4s)-1-[(2r)-2-[4-({[(2s,3s)-7,7-dichloro-1-[(1s)-2-hydroxy-1-[4-(methoxycarbonyl)-1,3-thiazol-2-yl]-2-methylpropoxy]-2-methyl-1-oxooctan-3-yl]oxy}carbonyl)-1,3-thiazol-2-yl]-2-hydroxyethoxy]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]butanimidic acid

n-[(3r,4s)-1-[(2r)-2-[4-({[(2s,3s)-7,7-dichloro-1-[(1s)-2-hydroxy-1-[4-(methoxycarbonyl)-1,3-thiazol-2-yl]-2-methylpropoxy]-2-methyl-1-oxooctan-3-yl]oxy}carbonyl)-1,3-thiazol-2-yl]-2-hydroxyethoxy]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]butanimidic acid

C36H53Cl2N3O12S2 (853.2448)


   

n-[(2s,3r,4r,5s,6r)-2-{[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-5-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-2-{[(2r,3s,4s,5r,6s)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-5-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C32H55NO25 (853.3063)


   

18,20,21,22,24-pentakis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-19-yl benzoate

18,20,21,22,24-pentakis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-19-yl benzoate

C42H47NO18 (853.2793)


   

(3s)-3-[(1s,4r,7s,14s,17s,20r,23s,31r)-7-tert-butyl-26,27-dichloro-2,15,18,31-tetrahydroxy-17-(methoxymethyl)-4-(1-methylcyclopropyl)-5,8,21-trioxo-6-oxa-3,9,10,16,19,22,24-heptaazapentacyclo[20.10.0.0⁹,¹⁴.0²³,³¹.0²⁵,³⁰]dotriaconta-2,15,18,25,27,29-hexaen-20-yl]-3-hydroxypropanoic acid

(3s)-3-[(1s,4r,7s,14s,17s,20r,23s,31r)-7-tert-butyl-26,27-dichloro-2,15,18,31-tetrahydroxy-17-(methoxymethyl)-4-(1-methylcyclopropyl)-5,8,21-trioxo-6-oxa-3,9,10,16,19,22,24-heptaazapentacyclo[20.10.0.0⁹,¹⁴.0²³,³¹.0²⁵,³⁰]dotriaconta-2,15,18,25,27,29-hexaen-20-yl]-3-hydroxypropanoic acid

C37H49Cl2N7O12 (853.2816)


   

(1r,3r,13r,14s,17r,18r,19r,20s,21s,22s,23s,24r,25s)-18,20,21,22,24-pentakis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-19-yl benzoate

(1r,3r,13r,14s,17r,18r,19r,20s,21s,22s,23s,24r,25s)-18,20,21,22,24-pentakis(acetyloxy)-25-hydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-19-yl benzoate

C42H47NO18 (853.2793)


   

3-[7-tert-butyl-26,27-dichloro-2,15,18,31-tetrahydroxy-17-(methoxymethyl)-4-(1-methylcyclopropyl)-5,8,21-trioxo-6-oxa-3,9,10,16,19,22,24-heptaazapentacyclo[20.10.0.0⁹,¹⁴.0²³,³¹.0²⁵,³⁰]dotriaconta-2,15,18,25,27,29-hexaen-20-yl]-3-hydroxypropanoic acid

3-[7-tert-butyl-26,27-dichloro-2,15,18,31-tetrahydroxy-17-(methoxymethyl)-4-(1-methylcyclopropyl)-5,8,21-trioxo-6-oxa-3,9,10,16,19,22,24-heptaazapentacyclo[20.10.0.0⁹,¹⁴.0²³,³¹.0²⁵,³⁰]dotriaconta-2,15,18,25,27,29-hexaen-20-yl]-3-hydroxypropanoic acid

C37H49Cl2N7O12 (853.2816)